Russia's CoviVac more than 80% effective against COVID-19: Ifax
Russia's third vaccine against COVID-19, CoviVac, is more than 80% effective according to preliminary data, the Interfax news agency cited the vaccine's developer as saying on Wednesday.
By Reuters |
Reuters
Russia's third vaccine against COVID-19, CoviVac, is more than 80% effective according to preliminary data, the Interfax news agency cited the vaccine's developer as saying on Wednesday.
The Chumakov Centre could produce six times more than the previously planned 10 million doses of the vaccine a year, Interfax added.
The Chumakov Centre could produce six times more than the previously planned 10 million doses of the vaccine a year, Interfax added.
Download
The Economic Times Business News App for the Latest News in Business, Sensex, Stock Market Updates & More.
The Economic Times Business News App for the Latest News in Business, Sensex, Stock Market Updates & More.
Download
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
ADVERTISEMENT
